These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 6452206)

  • 1. Advances in the treatment of heart failure.
    Mantle JA; Russell RO; Rogers WJ; Rackley CE
    Cardiovasc Clin; 1981; 11(3):49-64. PubMed ID: 6452206
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypertonic-hyperoncotic solutions improve cardiac function in children after open-heart surgery.
    Schroth M; Plank C; Meissner U; Eberle KP; Weyand M; Cesnjevar R; Dötsch J; Rascher W
    Pediatrics; 2006 Jul; 118(1):e76-84. PubMed ID: 16751617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Value of right ventricular ejection fraction in predicting short-term prognosis of patients with severe chronic heart failure.
    Gavazzi A; Berzuini C; Campana C; Inserra C; Ponzetta M; Sebastiani R; Ghio S; Recusani F
    J Heart Lung Transplant; 1997 Jul; 16(7):774-85. PubMed ID: 9257260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Does chronic oral treatment with beta-receptor blockers have an effect on positive inotropic therapy of coronary patients with adrenaline after extracorporeal circulation?].
    Günnicker M; Brinkmann M; Freund U; Piotrowski J; Schieffer M; Velser U
    Herz; 1995 Dec; 20(6):399-411. PubMed ID: 8582699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of recurrent heart failure associated with left ventricular assist device dysfunction.
    Jaski BE; Miller DA; Hoagland PM; Gordon JB; Chillcott SR; Stahovich MJ; Adamson RM; Baradarian S; Dembitsky WP
    J Heart Lung Transplant; 2005 Dec; 24(12):2060-7. PubMed ID: 16364850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemodynamic and neurohumoral effects of long-term prostaglandin E1 infusions in outpatients with severe congestive heart failure.
    Hülsmann M; Stanek B; Frey B; Berger R; Rödler S; Siegel A; Hartter E; Schuller M; Ogris E; Pacher R
    J Heart Lung Transplant; 1997 May; 16(5):556-62. PubMed ID: 9171275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of the hemodynamically unstable patient.
    Lee FA
    Cardiol Clin; 1988 Feb; 6(1):63-79. PubMed ID: 3048675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiac dysfunction in heart failure: the cardiologist's love affair with time.
    Brutsaert DL
    Prog Cardiovasc Dis; 2006; 49(3):157-81. PubMed ID: 17084177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathogenesis and management of acute heart failure and cardiogenic shock: role of inotropic therapy.
    McGhie AI; Golstein RA
    Chest; 1992 Nov; 102(5 Suppl 2):626S-632S. PubMed ID: 1424938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Left ventricular conditioning in the elderly patient to prevent congestive heart failure after transcatheter closure of atrial septal defect.
    Schubert S; Peters B; Abdul-Khaliq H; Nagdyman N; Lange PE; Ewert P
    Catheter Cardiovasc Interv; 2005 Mar; 64(3):333-7. PubMed ID: 15736252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Levosimendan in patients with low-output heart failure: lessons from the LIDO trial.
    Follath F
    Ital Heart J; 2003 May; 4 Suppl 2():34S-38S. PubMed ID: 14635368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pharmacotherapy of severe heart failure with inodilators--new approaches].
    Baumann G; Hader O
    Z Kardiol; 1996; 85 Suppl 4():9-19. PubMed ID: 9027110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Modern therapy of cardiac insufficiency].
    Stojsić D; Jelkić N
    Med Pregl; 1999; 52(3-5):113-24. PubMed ID: 10518395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The role of invasive procedures in the diagnosis of heart failure].
    Parsi RA
    Z Gesamte Inn Med; 1990 Jun; 45(12):337-40. PubMed ID: 1974729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The clinical experience with levosimendan in anesthesiology and in the intensive care unit.
    Cavana M; Pignataro C; Fraticelli A; Mebazaa A
    Ital Heart J; 2003 May; 4 Suppl 2():61S-64S. PubMed ID: 14635372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessing the treatment of congestive heart failure: diuretics, vasodilators, and angiotensin-converting enzyme inhibitors.
    Chow MS
    Pharmacotherapy; 1993; 13(5 Pt 2):82S-87S. PubMed ID: 8233997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hemodynamic effects of one administration of l-dopa in patients with left ventricular heart failure (introductory remarks)].
    Leszek P; Zieliński T; Korewicki J
    Kardiol Pol; 1993 May; 38(5):335-9. PubMed ID: 8366641
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiogenic shock.
    Rackley CE; Russell RO; Mantle JA; Rogers WJ
    Cardiovasc Clin; 1981; 11(3):15-24. PubMed ID: 7214388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Acute hemodynamic effects of alifedrine in patients with heart failure].
    Schanzenbächer P; Riegger G; Liebau G; Hockerts T; Kochsiek K
    Z Kardiol; 1984 Feb; 73(2):95-100. PubMed ID: 6719988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacologic therapies for acutely decompensated heart failure.
    Fonarow GC
    Rev Cardiovasc Med; 2002; 3 Suppl 4():S18-27. PubMed ID: 12439427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.